TRN 105
Alternative Names: TRN-105Latest Information Update: 28 Aug 2021
At a glance
- Originator Tris Pharma
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for clinical-Phase-Unknown development in Pain in USA (PO, Controlled release)
- 05 Jul 2018 Clinical trials in Pain in USA (PO) (Tris Pharma pipeline, July 2018)